CD8A and neoplasm: Piper et al. [20] showed that a combination of radiation and PD1-IL2v immunotherapy enhances CD8+ T cell polyfunctionality, activation, and immune memory across tumor, lymph node, and blood compartments and results in a durable local and systemic antitumor response.